Streetbeat News

Stock Prices

HLLY

Holley (NYSE:HLLY) reported Q2 earnings of $0.11 per share, beating the analyst consensus estimate of $0.06 by 83.33%. The company also reported quarterly sales of $175.30 million, surpassing the analyst consensus estimate of $172.61 million by 1.56%. However, this represents a 2.30% decrease over sales of $179.42 million from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 10, 2023 | 11:32 am

OCEA

Ocean Biomedical Inc (NASDAQ:OCEA) has shared updates on its programs in malaria, fibrosis, and multiple cancers. The company's early preclinical findings show significant tumor growth reduction in brain and lung cancers. It is also advancing its understanding of malaria parasite death mechanisms and developing an mRNA vaccine candidate. In fibrosis research, Ocean's anti-fibrotic treatment candidate, OCF-203, has shown impressive fibrosis reductions. The company's shares are up 3.53% in the premarket session.

Portfolio Pulse from Vandana Singh

August 10, 2023 | 11:30 am

PLUG

Plug Power, Inc. (NASDAQ:PLUG) shares fell in premarket trading after reporting Q2 revenue of $260.2 million, up 72% YoY, but with a gross margin of -30%, below the consensus estimate of -7%. The company did not reaffirm its 4-10% gross margin guidance for 2023. KeyBanc Capital Markets analyst Sangita Jain lowered her 2023 gross margin estimate from about 0% to -4%.

Portfolio Pulse from Shanthi Rexaline

August 10, 2023 | 11:26 am

FATE

Barclays analyst Peter Lawson maintains an Overweight rating on Fate Therapeutics (NASDAQ:FATE) but has lowered the price target from $12 to $6.

Portfolio Pulse from Benzinga Newsdesk

August 10, 2023 | 11:25 am

WWW

Wolverine World Wide reported Q2 results and lowered its full-year outlook, causing its shares to trade lower. The company also terminated the employment of Brendan Hoffman as CEO.

Portfolio Pulse from Benzinga Newsdesk

August 10, 2023 | 11:24 am

MKTW

Marketwise reported Q2 sales of $103.60 million, missing the analyst consensus estimate of $109.32 million by 5.23 percent. This represents a 19.07 percent decrease from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 10, 2023 | 11:20 am

OPTN

OptiNose, Inc. has updated its forecast for FY23 XHANCE net revenues to $64M-$70M, up from the previous estimate of $62M-$68M. The company also expects the average net revenue per prescription to be around $200.

Portfolio Pulse from Benzinga Newsdesk

August 10, 2023 | 11:18 am

BA

Boeing Company (NYSE:BA) sees Brazil as a potential key player in the production of sustainable aviation fuel (SAF) due to its leadership in biofuels. Brazil's capacity could help the aviation sector reach its goal of net-zero carbon emissions by 2050. However, ensuring sufficient SAF supply is a significant challenge for the industry. Boeing's shares are trading higher by 0.45% to $238.93 in the premarket.

Portfolio Pulse from Nabaparna Bhattacharya

August 10, 2023 | 11:16 am

ALYA

Alithya Group (NASDAQ:ALYA) reported Q1 earnings of $0.01 per share, beating the analyst consensus estimate of $(0.01) by 250 percent. However, the company's quarterly sales of $97.96 million missed the analyst consensus estimate of $104.69 million by 6.43 percent.

Portfolio Pulse from totan@benzinga.com

August 10, 2023 | 11:16 am

CYBR

CyberArk has released its 3Q23 revenue expectations, predicting a range of $181.5M-$186.5M, which is below the consensus of $187.14M. However, the company's adjusted EPS is expected to be between $0.19-$0.27, surpassing the consensus of $0.15. This represents a growth of 19-22% compared to the third quarter of 2022.

Portfolio Pulse from Benzinga Newsdesk

August 10, 2023 | 11:14 am